DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 20 filers reported holding DIREXION SHS ETF TR in Q3 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,706 | -11.5% | 200 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $20,002 | +4.2% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19,200 | -16.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $22,952 | +35.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | -19.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $21,000 | -19.2% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $26,000 | -10.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $29,000 | +38.1% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $21,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $21,000 | +23.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,000 | -45.2% | 200 | -50.0% | 0.00% | 0.0% |
| Q4 2020 | $31,000 | +24.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $25,000 | -51.9% | 400 | -58.3% | 0.00% | -66.7% |
| Q2 2020 | $52,000 | +36.8% | 960 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $38,000 | – | 960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 55,597 | $2,523,000 | 0.14% |
| Traynor Capital Management, Inc. | 7,481 | $341,000 | 0.12% |
| Virtu Financial LLC | 49,149 | $2,230,000 | 0.10% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 2,436 | $111,000 | 0.08% |
| Capital Analysts, LLC | 6,000 | $272,000 | 0.03% |
| Acorn Wealth Advisors, LLC | 395 | $18,000 | 0.02% |
| BANQUE PICTET & CIE SA | 10,120 | $459,000 | 0.01% |
| Citadel Advisors | 78,471 | $3,560,000 | 0.00% |
| WOLVERINE TRADING, LLC | 22,300 | $960,000 | 0.00% |
| JANE STREET GROUP, LLC | 21,346 | $968,000 | 0.00% |